Evofem Biosciences (EVFM) Asset Utilization Ratio (2020 - 2026)
Evofem Biosciences' (EVFM) Asset Utilization Ratio was 2.41 for Q2 2026, up 90.3% from 1.27 a year earlier and up 65.2% from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Asset Utilization Ratio (2020 - 2026) Analysis & Trends
For FY2025, Asset Utilization Ratio at Evofem Biosciences was 0.92, down 18.8% from FY2024.
- By year, Asset Utilization Ratio came in at 1.13 in FY2024 (+10.5%), 1.02 in FY2023 (+105.0%), 0.50 in FY2022 (+360.2%) and 0.11 in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Asset Utilization Ratio in data going back to Q3 2020.
- Year over year, Asset Utilization Ratio has now increased in each of the last four quarters, with growth averaging 11.2% over the last eight quarters.
- The high point for year-over-year Asset Utilization Ratio in five years was Q2 2022 (growth of 949.1%); the low point was Q1 2025 (a decline of 46.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 1.46 (Q1 2026), 1.18 (Q4 2025) and 1.26 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 0.31 |
| 10 | Evofem Biosciences | 878,961.72 | 878,961.72 | 2.12 Mn | 2.41 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.41 |
| Mar 31, 2026 | 1.46 |
| Dec 31, 2025 | 1.18 |
| Sep 30, 2025 | 1.26 |
| Jun 30, 2025 | 1.27 |
| Mar 31, 2025 | 0.91 |
| Dec 31, 2024 | 0.81 |
| Sep 30, 2024 | 1.05 |
| Jun 30, 2024 | 2.11 |
| Mar 31, 2024 | 1.71 |
| Dec 31, 2023 | 1.53 |
| Sep 30, 2023 | 0.99 |
| Jun 30, 2023 | 0.74 |
| Mar 31, 2023 | 0.72 |
| Dec 31, 2022 | 0.50 |
| Sep 30, 2022 | 0.42 |
| Jun 30, 2022 | 0.35 |
| Mar 31, 2022 | 0.30 |
| Dec 31, 2021 | 0.15 |
| Sep 30, 2021 | 0.05 |
API Access
Evofem Biosciences Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();